Cargando…

Reduced Serum Levels of Soluble Interleukin-15 Receptor α in Schizophrenia and Its Relationship to the Excited Phenotype

Our previous studies documented that interleukin-15 receptor α (IL-15Rα) knockout (KO) mice exhibited hyperactivity, memory impairment, and desperate behavior, which are core features of schizophrenia and depression. Due to the overlapping symptomology and pathogenesis observed for schizophrenia and...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Yi, Bo, Qijing, Mao, Zhen, Yang, Jian, Liu, Min, Wang, Haixia, Kastin, Abba J., Pan, Weihong, Wang, Chuanyue, Sun, Zuoli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959406/ https://www.ncbi.nlm.nih.gov/pubmed/35356722 http://dx.doi.org/10.3389/fpsyt.2022.842003

Ejemplares similares

Brain-Specific Oxysterols and Risk of Schizophrenia in Clinical High-Risk Subjects and Patients With Schizophrenia
por: Sun, Zuoli, et al.
Publicado: (2021)

Phenotypic Resemblance to Neuropsychiatric Disorder and Altered mRNA Profiles in Cortex and Hippocampus Underlying IL15Rα Knockout
por: He, Yi, et al.
Publicado: (2021)

Reduced Plasma Dopamine-β-Hydroxylase Activity Is Associated With the Severity of Bipolar Disorder: A Pilot Study
por: Sun, Zuoli, et al.
Publicado: (2021)

Core of sensory gating deficits in first-episode schizophrenia: attention dysfunction
por: Ding, Yushen, et al.
Publicado: (2023)

S15. ABNORMAL EYE TRACKING IN PATIENTS WITH SCHIZOPHRENIA UNDER THE SOCIAL SCENE
por: Bo, Qijing, et al.
Publicado: (2018)

TNF Stimulates Nuclear Export and Secretion of IL-15 by Acting on CRM1 and ARF6
por: Ouyang, Suidong, et al.
Publicado: (2013)

S72. MCCB COGNITIVE PROFILE IN CHINESE FIRST EPISODE SCHIZOPHRENIA PATIENTS AND SUBJECTS AT CLINICAL HIGH RISK FOR PSYCHOSIS
por: Lei, Zhao, et al.
Publicado: (2020)

Quality of life and its predictors in first-episode schizophrenia and individuals at clinical high-risk for psychosis
por: Mao, Zhen, et al.
Publicado: (2023)

T37. PREPULSE INHIBITION IN UNAFFECTED SIBLINGS OF SCHIZOPHRENIA AND CLINICAL-HIGH RISK WITHOUT FAMILY HISTORY OF PSYCHOSIS
por: Zhen, Mao, et al.
Publicado: (2020)

Interleukin-6 in Schizophrenia—Is There a Therapeutic Relevance?
por: Borovcanin, Milica Milovan, et al.
Publicado: (2017)

Low Field Magnetic Stimulation Ameliorates Schizophrenia-Like Behavior and Up-Regulates Neuregulin-1 Expression in a Mouse Model of Cuprizone-Induced Demyelination
por: Sun, Zuoli, et al.
Publicado: (2018)

F57. CORRELATION FACTORS OF ABNORMAL MENSES IN SCHIZOPHRENIA TREATMENT WITH RISPERIDONE
por: Dong, Fang, et al.
Publicado: (2018)

A neural model of modified excitation/inhibition and feedback levels in schizophrenia
por: Zhu, Jiating, et al.
Publicado: (2023)

Fibroblast growth factor 19 entry into brain
por: Hsuchou, Hung, et al.
Publicado: (2013)

Which Subgroup of First-Episode Schizophrenia Patients Can Remit During the First Year of Antipsychotic Treatment?
por: Cheng, Zhang, et al.
Publicado: (2020)

Autism Spectrum Disorders and Schizophrenia Spectrum Disorders: Excitation/Inhibition Imbalance and Developmental Trajectories
por: Canitano, Roberto, et al.
Publicado: (2017)

Examining the Causal Inference of Leptin and Soluble Plasma Leptin Receptor Levels on Schizophrenia: A Mendelian Randomization Study
por: Chen, Guoqing, et al.
Publicado: (2021)

Cannabis Use Is Associated With Increased Levels of Soluble gp130 in Schizophrenia but Not in Bipolar Disorder
por: Szabo, Attila, et al.
Publicado: (2020)

Effects of olanzapine on anhedonia in schizophrenia: mediated by complement factor H
por: Zhang, Yi, et al.
Publicado: (2023)

Reduced Plasma Levels of α-Klotho and Their Correlation With Klotho Polymorphisms in Elderly Patients With Major Depressive Disorders
por: Gao, Xiang, et al.
Publicado: (2021)

Aberrant Functional Connectivity of the Orbitofrontal Cortex Is Associated With Excited Symptoms in First-Episode Drug-Naïve Patients With Schizophrenia
por: Chen, Congxin, et al.
Publicado: (2022)

15 Years of Microstate Research in Schizophrenia – Where Are We? A Meta-Analysis
por: Rieger, Kathryn, et al.
Publicado: (2016)

A 1.5-Year Longitudinal Study of Social Activity in Patients With Schizophrenia
por: Ohi, Kazutaka, et al.
Publicado: (2019)

M2-AChR Mediates Rapid Antidepressant Effects of Scopolamine Through Activating the mTORC1-BDNF Signaling Pathway in the Medial Prefrontal Cortex
por: Liu, Shuang, et al.
Publicado: (2021)

Autism Rating Scale: A New Tool for Characterizing the Schizophrenia Phenotype
por: Palumbo, Davide, et al.
Publicado: (2021)

Machine Learning-Based Electroencephalographic Phenotypes of Schizophrenia and Major Depressive Disorder
por: Jang, Kuk-In, et al.
Publicado: (2021)

Development and Internal Validation of a Novel Model to Identify Inflammatory Biomarkers of a Response to Escitalopram in Patients With Major Depressive Disorder
por: Zhou, Jingjing, et al.
Publicado: (2021)

Prolactin related symptoms during risperidone maintenance treatment: results from a prospective, multicenter study of schizophrenia
por: Bo, Qijing, et al.
Publicado: (2016)

Multidimensional Connectomics and Treatment-Resistant Schizophrenia: Linking Phenotypic Circuits to Targeted Therapeutics
por: MacKay, Mary-Anne B., et al.
Publicado: (2018)

False Dogmas in Schizophrenia Research: Toward the Reification of Pathway Phenotypes and Pathway Classes
por: Maes, Michael, et al.
Publicado: (2021)

Association of BDNF and MMP-9 single-nucleotide polymorphisms with the clinical phenotype of schizophrenia
por: Pan, Lihong, et al.
Publicado: (2022)

Interleukin-15 and Soluble Interleukin-15 Receptor α in Coronary Artery Disease Patients: Association with Epicardial Fat and Indices of Adipose Tissue Distribution
por: Dozio, Elena, et al.
Publicado: (2014)

Leptin Methylation and mRNA Expression Associated With Psychopathology in Schizophrenia Inpatients
por: Song, Jiaqi, et al.
Publicado: (2022)

Risk Factor for Retreatment Episode on Admission Among TB Patients With Schizophrenia
por: Wang, Hai-Rong, et al.
Publicado: (2021)

CNVs and Chromosomal Aneuploidy in Patients With Early-Onset Schizophrenia and Bipolar Disorder: Genotype-Phenotype Associations
por: Gregoric Kumperscak, Hojka, et al.
Publicado: (2021)

Safety and Effectiveness of Blonanserin in Chinese Patients with Schizophrenia: An Interim Analysis of a 12-Week Open-Label Prospective Multi-Center Post-marketing Surveillance
por: Wu, Haishan, et al.
Publicado: (2022)

Use of the MATRICS consensus cognitive battery (MCCB) to evaluate cognitive deficits in bipolar disorder: A systematic review and meta-analysis
por: Bo, Qijing, et al.
Publicado: (2017)

Prepulse inhibition in patients with bipolar disorder: a systematic review and meta-analysis
por: Mao, Zhen, et al.
Publicado: (2019)

Optimal cutoff scores of the Chinese version of 15-item negative symptom assessment that indicate prominent negative symptoms of schizophrenia
por: Zhou, Qi, et al.
Publicado: (2023)

Dopamine Rebound-Excitation Theory: Putting Brakes on PTSD
por: Lee, Jason C., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_clk3ndmu1toqord79o121fcnmr